CRP and thrombophilia: The patient cohort undergoing palliative surgery had raised serum CRP measurements (41.7% vs. 16.0%, p < 0.001), hypoalbuminaemia (36.1% vs. 16.7%, p = 0.005), higher mGPS (27.8% vs. 6.6%, p < 0.001), thrombophilia (13.9% vs. 2.7%, p = 0.001), higher NPS (2.8% vs 0.3%, p = 0.006), and were more likely to have received neoadjuvant chemotherapy (91.4% vs. 70.4%, p = 0.008).